Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy
Authors
Keywords
-
Journal
ACS Nano
Volume 16, Issue 7, Pages 11325-11337
Publisher
American Chemical Society (ACS)
Online
2022-07-12
DOI
10.1021/acsnano.2c04982
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Engineered Bacteria for Enhanced Radiotherapy against Breast Carcinoma
- (2022) Pei Pan et al. ACS Nano
- Plasmacytoid Dendritic Cells and Cancer Immunotherapy
- (2022) Chunmei Fu et al. Cells
- Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria
- (2022) Wenguang Wang et al. Nature Biomedical Engineering
- Bacterial couriers as cancer vaccines
- (2022) Andrew Redenti et al. Nature Biomedical Engineering
- Targeting metastatic cancer
- (2021) Karuna Ganesh et al. NATURE MEDICINE
- Nanomaterials for T-cell cancer immunotherapy
- (2021) Ningqiang Gong et al. Nature Nanotechnology
- Nanobiomaterial-based vaccination immunotherapy of cancer
- (2021) Fangmin Chen et al. BIOMATERIALS
- Genomic evolution and diverse models of systemic metastases in colorectal cancer
- (2021) Hai-Ning Chen et al. GUT
- Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade
- (2021) Wei Si et al. GUT
- Bacteria‐Based Cancer Immunotherapy
- (2021) Xuehui Huang et al. Advanced Science
- Exploring innate immunity in cancer immunotherapy: opportunities and challenges
- (2021) Xiaolei Li et al. Cellular & Molecular Immunology
- PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
- (2021) Julia Koerner et al. Nature Communications
- Radionuclide labeled gold nanoclusters boost effective anti-tumor immunity for augmented radio-immunotherapy of cancer
- (2021) Pei Pei et al. Nano Today
- Self‐Blockade of PD‐L1 with Bacteria‐Derived Outer‐Membrane Vesicle for Enhanced Cancer Immunotherapy
- (2021) Jingmei Pan et al. ADVANCED MATERIALS
- Dendritic cells, the T cell-inflamed tumor microenvironment and immunotherapy treatment response
- (2020) Christopher S. Garris et al. CLINICAL CANCER RESEARCH
- Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
- (2020) Daniel S. Leventhal et al. Nature Communications
- Bacterial-induced cell fusion is a danger signal triggering cGAS–STING pathway via micronuclei formation
- (2020) Joanne Wei Kay Ku et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adaptive T cell immunotherapy in cancer
- (2020) Dongdong Ti et al. Science China-Life Sciences
- Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
- (2020) Hans Raskov et al. BRITISH JOURNAL OF CANCER
- A DNA nanodevice-based vaccine for cancer immunotherapy
- (2020) Shaoli Liu et al. NATURE MATERIALS
- Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer
- (2020) Xuan Yi et al. Science Advances
- Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy
- (2020) Vyara Matson et al. GASTROENTEROLOGY
- Programmable bacteria induce durable tumor regression and systemic antitumor immunity
- (2019) Sreyan Chowdhury et al. NATURE MEDICINE
- DNA sensing by the cGAS–STING pathway in health and disease
- (2019) Mona Motwani et al. NATURE REVIEWS GENETICS
- Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial‐Membrane‐Coated Nanoparticles
- (2019) Ravi B. Patel et al. ADVANCED MATERIALS
- Nanomedicine‐Based Immunotherapy for the Treatment of Cancer Metastasis
- (2019) Pengcheng Zhang et al. ADVANCED MATERIALS
- Harnessing innate immunity in cancer therapy
- (2019) Olivier Demaria et al. NATURE
- Bacteria-cancer interactions: bacteria-based cancer therapy
- (2019) Mai Thi-Quynh Duong et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest
- (2019) Alexandre Pichard et al. LEUKEMIA
- Nanoparticle-mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
- (2018) Xiaopin Duan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†
- (2018) Peter M Hawkey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Polymer nanoparticles as adjuvants in cancer immunotherapy
- (2018) Shengxian Li et al. Nano Research
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- The role of bacteria in cancer therapy – enemies in the past, but allies at present
- (2018) Shiyu Song et al. Infectious Agents and Cancer
- Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
- (2018) Yu Chao et al. Nature Biomedical Engineering
- Cross-talk between bacterial PAMPs and host PRRs
- (2018) Yanfang Zhai et al. National Science Review
- Polydopamine as a Biocompatible Multifunctional Nanocarrier for Combined Radioisotope Therapy and Chemotherapy of Cancer
- (2015) Xiaoyan Zhong et al. ADVANCED FUNCTIONAL MATERIALS
- Radionuclide 131I labeled reduced graphene oxide for nuclear imaging guided combined radio- and photothermal therapy of cancer
- (2015) Lei Chen et al. BIOMATERIALS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started